More importantly, we examined the clinical data of patients with glioma in the CGGA database and revealed that RRM2 expression was inversely correlated with the OS time, indicating that RRM2 may be a prognosis marker of GBM (Figure 7F). Here, RRM2 is linked to glioblastoma.